Gain-of-function mutations in the PCSK9 gene result in increased blood PCSK9 protein levels, LDL receptor degradation, and increased blood LDL-C, which causes familial hypercholesterolemia. The gene discussed is LDLR; the disease is familial hypercholesterolemia.